The company plans to use the newly secured funding to expand the indications of its Grabody platform into high-unmet-need areas
The initiative is focused on a problem that continues to plague cancer outcomes in India
The expansion includes a larger technical and service team and increased local procurement
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Valorum will advance the commercialization and distribution of Armlupeg in the United States
Now a test that offers new precision in prostate cancer detection
Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division
Subscribe To Our Newsletter & Stay Updated
